Public company research profile

This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.

Open in CopyWindow

Company research history

Marathon Oil Corporation (MRO)

Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.

8 disclosures
3 insiders
0 cluster signals
0.0% avg. 30d outcome

Company facts

Ticker / ISIN
MRO / Not available
Exchange
Not available
Country
US
Sector
Not available

Disclosure history

Lance Gooden, Representative

sell disclosed on 6 Sept 2024 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Virginia Foxx, Representative

sell disclosed on 3 Mar 2023 via House STOCK Act disclosures

Transaction value
Not available
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Virginia Foxx, Representative

buy disclosed on 3 Jan 2023 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Virginia Foxx, Representative

buy disclosed on 6 Dec 2022 via House STOCK Act disclosures

Transaction value
Not available
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Virginia Foxx, Representative

buy disclosed on 6 Dec 2022 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Virginia Foxx, Representative

buy disclosed on 3 Nov 2022 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Kathy Manning, Representative

sell disclosed on 14 Sept 2022 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Kathy Manning, Representative

buy disclosed on 10 Aug 2022 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%